Salus Wellness welcomes Emily Woollins to the team
Emily is an experienced Nutritional Therapist specializing in supporting clients with IBS (Irritable Bowel Syndrome) and other digestive disorders. She regularly works with clients suffering with pain, bloating, fatigue and suspected food intolerances.
Guardtech Group December Wrap-Up: a year of huge growth, joy and goodwill to all
As 2022 comes to a close, cleanroom construction specialists Guardtech joyously celebrate their busiest ever year.
How eligible patient numbers affect price of rare disease drugs in France
Having recently assessed the relationship between drug price and prevalence of non-oncology rare diseases, CRA’s Cécile Matthews, Bhavesh Patel, and Owen Male explore in greater depth the situation for these orphan drug
France’s ATU reform: Early access remains possible, but not all diseases are equal
When France’s ATU reform was implemented, some viewed it as restrictive.
Cambridge & Huntingdon based property firm Rapleys makes biggest acquisition in 72 years
London, UK - Rapleys announces it has welcomed London surveying firm Aston Rose into its business, the biggest single expansion in the partnership's 72 year history. The property consultancy has been on a strategic growth drive in recent months having onboarded planning practice CSJ in October and rebranding and repositioning the business in November.
The Native Antigen Company expands infectious disease portfolio to include Sudan Ebolavirus Boniface 1976 Glycoprotein
Antigen designed to support immunoassay and vaccine development applications
Leading UK Diagnostics provider Source LDPath expands AI capabilities with Ibex Medical Analytics
NHS Trusts Gain Access to Galen, Ibex's Multi-tissue AI Platform, Supporting Pathologists with Enhanced Diagnostic Accuracy and Efficiency
Metrion Biosciences and The KCNC1 Foundation collaborate on development of new ion channel modulators for ultra-rare genetic disorder
Research targeted at identifying novel inhibitors or activators of Kv3.1 mutation
A keynote speech for Envu
In October, Bayer sold its Environmental Science business to PE firm Cinven for $2.6B.
Owlstone Medical launches Breath Biopsy VOC Atlas
Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the launch of the Breath Biopsy VOC Atlas, a catalogue of validated and qua
Sync Neural Synchronised Impact fund: the ultimate investment vehicle to save the world?
London & Cambridge (UK) and Lucerne (Switzerland) - Sync Neural, the Swiss based holding company that addresses carbon neutrality, has signed a product partnership agreement with AlgoDynamix, the leader in behavioural-based price forecasting for financial markets. New investment products, including a Global Synchronised Impact fund, are expected in Q1 2023.
Shenandoah Biotechnology introduces expanded range of CTGrade recombinant proteins manufactured following cGMP practices
Shenandoah Biotechnology Inc., a FUJIFILM Irvine Scientific company and leading manufacturer of recombinant proteins, today announced it has expanded its CTGrade portfolio of cytokines and growth factors for cell a
Mitigating risk: A conversation with Biocair's Sarah Pentney
Sarah Pentney, Biocair’s Global Quality and Compliance Manager, discusses how to stay up-to-date on the regulatory landscape and what is involved in mitigating risk when shipping Active Pharmaceutical Ingredients (APIs) and finished drug products.
Webcasting Plan B
“We pay you for when it goes wrong not for when it goes right” Roy Shepard executive producer explains why you need an experienced webcasting crew and always have a plan B.
Anne Glover and Hermann Hauser, reflecting on 25 years of Amadeus Capital Partners
As Amadeus celebrates 25 years since it was founded, Partner Amelia Armour sits down with Hermann Hauser and Anne Glover to reflect on the past three decades in our latest podcast episode.
Klebsiella pneumoniae vaccines - time to reprioritize
This month VacZine Analytics, a UK-based strategic research publisher exclusively focused on vaccines and infectious diseases, releases a brand-new global forecast of new Klebsiella pneumoniae vaccines.
International Day of Persons with Disabilities
International Day of Persons with Disabilities - an annual campaign aiming to join communities together to support people with disabilities and create a future for them where they experience equal opportunities and face no barriers in all aspects of their lives including employment.
South Africa expansion delivers growth opportunities for Biocair
Biocair has invested heavily in the expansion of its South Africa operation with the opening of two new offices.
Life-saving ambulance service marks birthday
A life-saving service for critically ill and injured hospital patients celebrates its first birthday today.
Cresset CEO’s end of year message 2022
As we near the end of another year, Dr Robert Scoffin, CEO of Cresset, reflects on the events of 2022
ARU vision experts receive high-profile recognition
College of Optometrists bestows awards for ‘outstanding achievements’ in the field.
AstraZeneca to acquire Neogene Therapeutics, accelerating ambition in Oncology cell therapy
Acquisition provides access to next-generation T-cell receptor therapies with promising potential for targeting solid tumours.
Metrion Biosciences invests in new High Throughput Screening capability and expanded facilities
Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced the launch of its High Throughput Screening (HTS) capability, as well as the expansion of its state-of-the-art lab and office facil
Cambridgeshire mum is SheInspires National Agent of Change
A Cambridgeshire mum of two is celebrating after winning an international She Inspires award for her women’s health campaign.